Last edition
News about "Drugs Controller General of India "
Akums Becomes First Indian CDMO to Receive DCGI Approval for Innovative Glaucoma Treatment
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide, with India contributing to 23.5 percent of the global burden.
Drugs Controller General Of India | 01/04/2025 | By Abha
CDSCO Launches Digital Portal to Simplify Extension Process for Pharma MSMEs
This initiative is integrated into the Online National Drugs Licensing System (ONDLS) and follows the Health Ministry's notification granting an extension for compliance with updated Good Manufacturing Practices (GMP).
Drugs Controller General Of India | 26/03/2025 | By Aishwarya | 124
Akums Combines Two Potent Diabetes Medicines for Enhanced Treatment Efficacy
Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, aids in eliminating excess glucose via urine while delivering additional benefits such as improved cardiovascular and renal outcomes, along with better weight management.
Drugs Controller General Of India | 03/02/2025 | By Aishwarya | 108
Orchid Pharma Gets DCGI Approval for Enmetazobactam
Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.
Drugs Controller General Of India | 10/06/2024 | By Aishwarya | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy